Cardiovascular Risk Factors and Secondary Events Among Acute and Chronic Stable Myocardial Infarction Patients: Findings from a Managed Care Database

被引:3
作者
Bash, Lori D. [1 ]
White, Kellee [2 ]
Patel, Mehul D. [3 ]
Liu, Jinan [4 ]
Mavros, Panagiotis [4 ]
Mahaffey, Kenneth W. [5 ]
机构
[1] Merck & Co Inc, Kenilworth, NJ 07033 USA
[2] Univ Maryland, Sch Publ Hlth, Dept Hlth Serv Adm, College Pk, MD 20742 USA
[3] Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27515 USA
[4] Janssen Pharmaceut Co Johnson & Johnson, Titusville, NJ USA
[5] Stanford Univ, Dept Med, Sch Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA
关键词
Acute coronary syndrome; Mortality; Myocardial infarction; Stable ischemic heart disease; ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; PREVENTION; VORAPAXAR; STRATIFICATION; PATTERNS; OUTCOMES; DISEASE; HEART; SCORE;
D O I
10.1007/s40119-019-00147-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Long-term risk for recurrent cardiovascular events among myocardial infarction (MI) patients in the acute versus chronic stable phase is not well characterized. This study was conducted to evaluate risk factors associated with all-cause mortality and cardiovascular (CVD) morbidity and to determine the transition period from the acute to chronic stable phase of disease. Methods: Administrative claims data from a managed care database (2007-2012) were linked to the Social Security Death Index. Kaplan-Meier curves were generated over a 3-year period. The association between risk factors and clinical endpoints was assessed using Cox proportional hazard models. Poisson models estimated the 'transition time' from acute to chronic phase of disease. Results: On average, recurrent cardiovascular event rates were higher among acute MI patients in comparison to the chronic MI patients during the first 3 months of follow-up. Over the 3-year follow-up period, survival curves became parallel and for some outcomes (i.e., acute myocardial infarction and bleeding events), were not statistically significantly different between the two groups. In both the acute and chronic MI cohorts, diabetes, heart failure, and renal disease were consistently statistically significant and positively associated with greater risk of death and ischemic events. PAD was consistently associated with increased risk among the chronic cohort and composite endpoints among the acute patients. Conclusions: Greater understanding of differences in the CVD risk profiles and the transition from acute to chronic stable phase may help identify high-risk patients and inform clinical risk stratification and long-term disease management in MI patients.FundingMerck & Co., Inc., Kenilworth, NJ, USA.
引用
收藏
页码:329 / 343
页数:15
相关论文
共 22 条
  • [1] Acute coronary syndrome and stable coronary artery disease: Are they so different? Long-term outcomes in a contemporary PCI cohort
    Alcock, R. F.
    Yong, A. S. C.
    Ng, A. C. C.
    Chow, V.
    Cheruvu, C.
    Aliprandi-Costa, B.
    Lowe, H. C.
    Kritharides, L.
    Brieger, D. B.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1343 - 1346
  • [2] Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000-2007
    Aliprandi-Costa, Bernadette
    Ranasinghe, Isuru
    Chow, Vincent
    Kapila, Shruti
    Juergens, Craig
    Devlin, Gerard
    Elliott, John
    Lefkowitz, Jeff
    Brieger, David B.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2011, 195 (03) : 116 - 121
  • [3] The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making
    Antman, EM
    Cohen, M
    Bernink, PJLM
    McCabe, CH
    Horacek, T
    Papuchis, G
    Mautner, B
    Corbalan, R
    Radley, D
    Braunwald, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07): : 835 - 842
  • [4] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [5] Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study
    Beatty, Alexis L.
    Ku, Ivy A.
    Bibbins-Domingo, Kirsten
    Christenson, Robert H.
    DeFilippi, Christopher R.
    Ganz, Peter
    Ix, Joachim H.
    Lloyd-Jones, Donald
    Omland, Torbjorn
    Sabatine, Marc S.
    Schiller, Nelson B.
    Shlipak, Michael G.
    Skali, Hicham
    Takeuchi, Madoka
    Vittinghoff, Eric
    Whooley, Mary A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (07):
  • [6] Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
    Bhatt, Deepak L.
    Eagle, Kim A.
    Ohman, E. Magnus
    Hirsch, Alan T.
    Goto, Shinya
    Mahoney, Elizabeth M.
    Wilson, Peter W. F.
    Alberts, Mark J.
    D'Agostino, Ralph
    Liau, Chiau-Suong
    Mas, Jean-Louis
    Roether, Joachim
    Smith, Sidney C., Jr.
    Salette, Genevieve
    Contant, Charles F.
    Massaro, Joseph M.
    Steg, Ph. Gabriel
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (12): : 1350 - 1357
  • [7] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Bhatt, DL
    Fox, KAA
    Hacke, W
    Berger, PB
    Black, HR
    Boden, WE
    Cacoub, P
    Cohen, EA
    Creager, MA
    Easton, JD
    Flather, MD
    Haffner, SM
    Hamm, CW
    Hankey, GJ
    Johnston, SC
    Mak, KH
    Mas, JL
    Montalescot, G
    Pearson, TA
    Steg, PG
    Steinhubl, SR
    Weber, MA
    Brennan, DM
    Fabry-Ribaudo, L
    Booth, J
    Topol, EJ
    Frye, RL
    Amarenco, P
    Brass, LM
    Buyse, M
    Cohen, LS
    DeMets, DL
    Fuster, V
    Hart, RG
    Marler, JR
    McCarthy, C
    Schoemig, A
    Lincoff, AM
    Brener, SJ
    Sila, CA
    Albuquerque, A
    Aroutiounov, G
    Artemiev, D
    Atkeson, BG
    Bartel, T
    Basart, DCG
    Lima, AB
    Belli, G
    Bordalo e Sa, AL
    Bosch, X
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) : 1706 - 1717
  • [8] Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction
    Bohula, Erin A.
    Bonaca, Marc P.
    Braunwald, Eugene
    Aylward, Philip E.
    Corbalan, Ramon
    De Ferrari, Gaetano M.
    He, Ping
    Lewis, Basil S.
    Merlini, Piera A.
    Murphy, Sabina A.
    Sabatine, Marc S.
    Scirica, Benjamin M.
    Morrow, David A.
    [J]. CIRCULATION, 2016, 134 (04) : 304 - +
  • [9] Choi Sun Young, 2018, TH Open, V2, pe399, DOI 10.1055/s-0038-1675576
  • [10] Identifying Patients at High Risk of a Cardiovascular Event in the Near Future Current Status and Future Directions: Report of a National Heart, Lung, and Blood Institute Working Group
    Eagle, Kim A.
    Ginsburg, Geoffrey S.
    Musunuru, Kiran
    Aird, William C.
    Balaban, Robert S.
    Bennett, Susan K.
    Blumenthal, Roger S.
    Coughlin, Shaun R.
    Davidson, Karina W.
    Frohlich, Edward D.
    Greenland, Philip
    Jarvik, Gail P.
    Libby, Peter
    Pepine, Carl J.
    Ruskin, Jeremy N.
    Stillman, Arthur E.
    Van Eyk, Jennifer E.
    Tolunay, H. Eser
    McDonald, Cheryl L.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2010, 121 (12) : 1447 - 1454